Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 6/20 | 0.67 |
| ▸ | CA12 | O43570 | 5/20 | 0.67 |
| ▸ | CA2 | P00918 | 5/20 | 0.67 |
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA7 | P43166 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | BCHE | P06276 | 1/20 | 0.67 |
| ▸ | CA6 | P23280 | 1/20 | 0.67 |
| ▸ | CA5A | P35218 | 1/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.67 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.48 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.48 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL3816 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL4199164 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL588640 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL4777123 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL6049140 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL29358404 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL29191365 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL7073018 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL6033672 | 0.80 | CA12 (1.00) | CA9CA12CA2CA1CA4 | |
| Saccharin SCHEMBL2526712 | 0.78 | CA12 (0.96) | CA9CA12CA2CA1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287032-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | MERCK SHARP & DOHME LLC (US) | 2023-09-14 | — | — | US | claimed |
| EP-4196131-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | Merck Sharp & Dohme LLC (US) | 2023-06-21 | — | — | EP | claimed |
| WO-2022035917-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | MERCK SHARP & DOHME CORP. (US) | 2022-02-17 | — | — | WO | claimed |
| EP-0403366-B1 | Cyclomalto-oligosaccharide derivatives and processes for their preparation | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1995-02-22 | — | — | EP | claimed |
| EP-0403366-A2 | Cyclomalto-oligosaccharide derivatives and processes for their preparation | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-12-19 | — | — | EP | claimed |
| JP-6211888-A | — | — | None | — | — | JP | disclosed |
| US-12422394-B2 | Devices and methods including a preconcentrator material for detection of analytes | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-09-23 | — | — | US | disclosed |
| US-20240274855-A1 | HIGH ENERGY DENSITY REDOX FLOW DEVICE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-08-15 | — | — | US | disclosed |
| US-20230287032-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | MERCK SHARP & DOHME LLC (US) | 2023-09-14 | — | — | US | disclosed |
| EP-4196131-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | Merck Sharp & Dohme LLC (US) | 2023-06-21 | — | — | EP | disclosed |
| EP-2606529-B1 | ELECTROCHEMICAL CELL | MASSACHUSETTS INST TECHNOLOGY (US) | 2022-11-23 | — | — | EP | disclosed |
| US-20220057352-A1 | DEVICES AND METHODS INCLUDING A PRECONCENTRATOR MATERIAL FOR DETECTION OF ANALYTES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-02-24 | — | — | US | disclosed |
| US-5736533-A | INHIBITING COLONIZATION OF STREPTOCOCCUS PNEUMONIAE, HEMOPHILUS INFLUENZA OR PARAINFLUENZA, BURKHOLDERIA (PSEUDOMONAS) CEPACIA BY ADMINISTERING BINDING INHIBITING OLIGOSACCHARIDE | NEOSE TECHNOLOGIES, INC. (US) | 1998-04-07 | — | — | US | disclosed |
| WO-1996040169-A1 | BACTERIAL INHIBITION WITH AN OLIGOSACCHARIDE COMPOUND | NEOSE TECHNOLOGIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0403366-B1 | Cyclomalto-oligosaccharide derivatives and processes for their preparation | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1995-02-22 | — | — | EP | disclosed |
| JP-H06211888-A | NEW 16-MEMBERED RING MACROLIDE DERIVATIVE AND ITS PRODUCTION | MEIJI SEIKA KAISHA LTD | 1994-08-02 | — | — | JP | disclosed |
| EP-0403366-A2 | Cyclomalto-oligosaccharide derivatives and processes for their preparation | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-12-19 | — | — | EP | disclosed |
| EP-0337229-A2 | Substituted pyri(mi)dines | BAYER AG (DE) | 1989-10-18 | — | — | EP | disclosed |
| EP-0327913-A2 | Substituted azolyl methyl oxiranes | BAYER AG (DE) | 1989-08-16 | — | — | EP | disclosed |
| EP-0327899-A2 | Substituted vinyl azoles | BAYER AG (DE) | 1989-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287032-A1 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | NUDT1, NT5C3B, DUT | CA9 3944/4885CA12 4864/4885CA2 4148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.